Aln-htt02, Alnylam Alny Stock, Alnylam Pharmaceuticals, Alnylam Rnai Roundtable, Brezosiran, Huntingtin, Huntingtin Lowering, Huntington's Disease, Huntington's Disease Clinical Trial, Huntington's Disease Treatment, Intrathecal Rnai Therapy, Mutant Huntingtin (mhtt), Phase 1b Clinical Trial Results, Rnai Therapeutics